AU Stock MarketDetailed Quotes

OSLO OncoSil Medical Ltd

Watchlist
  • 0.001
  • 0.0000.00%
20min DelayMarket Closed Nov 12 15:12 AET
4.48MMarket Cap0.00P/E (Static)

OncoSil Medical Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
Operating cash flow (direct method)
Cash income from operating activities
15.50%1.38M
8.48%1.19M
-64.79%1.1M
-18.05%3.12M
-11.16%3.81M
24.37%4.29M
3.45M
Revenue from customers
-25.23%277K
38.67%370.48K
26.65%267.16K
--210.94K
----
----
----
Income from government grants
33.87%1.1M
-1.22%821.48K
-71.42%831.6K
3,169.07%2.91M
--89K
----
----
Other cash income from operating activities
----
----
----
----
-13.23%3.72M
24.37%4.29M
--3.45M
Cash paid
2.35%-12.26M
-12.14%-12.56M
6.69%-11.2M
-43.61%-12M
30.30%-8.36M
-0.03%-11.99M
-11.99M
Payments to suppliers for goods and services
2.35%-12.26M
-12.14%-12.56M
6.69%-11.2M
-43.61%-12M
30.30%-8.36M
-0.03%-11.99M
---11.99M
Direct interest paid
63.82%-3.94K
44.46%-10.9K
-24.62%-19.62K
-42.06%-15.75K
---11.09K
----
----
Direct interest received
6.32%66.57K
517.97%62.61K
-87.72%10.13K
-21.36%82.48K
-48.62%104.88K
41.00%204.11K
--144.76K
Operating cash flow
4.34%-10.82M
-11.92%-11.32M
-14.69%-10.11M
-97.83%-8.82M
40.59%-4.46M
10.67%-7.5M
---8.4M
Investing cash flow
Cash flow from continuing investing activities
-240.82%-197.06K
-891.41%-57.82K
89.20%-5.83K
-160.61%-54K
-39.74%-20.72K
-38.63%-14.83K
-10.7K
Net PPE purchase and sale
-240.82%-197.06K
-891.41%-57.82K
89.20%-5.83K
-160.61%-54K
-39.74%-20.72K
-38.63%-14.83K
---10.7K
Cash from discontinued investing activities
Investing cash flow
-240.82%-197.06K
-891.41%-57.82K
89.20%-5.83K
-160.61%-54K
-39.74%-20.72K
-38.63%-14.83K
---10.7K
Financing cash flow
Cash flow from continuing financing activities
-35.40%6.13M
3.62%9.49M
8,129.98%9.16M
-99.37%111.25K
17.79M
15.61M
Net issuance payments of debt
----
----
----
-200.00%-26.56K
--26.56K
----
----
Net common stock issuance
-36.02%6.19M
3.85%9.67M
3,483.17%9.32M
-98.55%260K
--17.88M
----
--15.61M
Net other financing activities
67.74%-60.4K
-16.84%-187.21K
-31.14%-160.23K
-0.90%-122.18K
---121.1K
----
----
Cash from discontinued financing activities
Financing cash flow
-35.40%6.13M
3.62%9.49M
8,129.98%9.16M
-99.37%111.25K
--17.79M
----
--15.61M
Net cash flow
Beginning cash position
-16.72%9.39M
-7.84%11.28M
-41.71%12.24M
173.08%21M
-49.43%7.69M
90.05%15.21M
--8M
Current changes in cash
-159.41%-4.89M
-96.46%-1.89M
89.04%-960K
-165.81%-8.76M
277.07%13.31M
-204.32%-7.52M
--7.2M
End cash Position
-52.08%4.5M
-16.72%9.39M
-7.84%11.28M
-41.71%12.24M
173.08%21M
-49.43%7.69M
--15.21M
Free cash from
3.10%-11.02M
-12.43%-11.37M
-14.06%-10.12M
-98.12%-8.87M
40.44%-4.48M
10.61%-7.52M
---8.41M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018
Operating cash flow (direct method)
Cash income from operating activities 15.50%1.38M8.48%1.19M-64.79%1.1M-18.05%3.12M-11.16%3.81M24.37%4.29M3.45M
Revenue from customers -25.23%277K38.67%370.48K26.65%267.16K--210.94K------------
Income from government grants 33.87%1.1M-1.22%821.48K-71.42%831.6K3,169.07%2.91M--89K--------
Other cash income from operating activities -----------------13.23%3.72M24.37%4.29M--3.45M
Cash paid 2.35%-12.26M-12.14%-12.56M6.69%-11.2M-43.61%-12M30.30%-8.36M-0.03%-11.99M-11.99M
Payments to suppliers for goods and services 2.35%-12.26M-12.14%-12.56M6.69%-11.2M-43.61%-12M30.30%-8.36M-0.03%-11.99M---11.99M
Direct interest paid 63.82%-3.94K44.46%-10.9K-24.62%-19.62K-42.06%-15.75K---11.09K--------
Direct interest received 6.32%66.57K517.97%62.61K-87.72%10.13K-21.36%82.48K-48.62%104.88K41.00%204.11K--144.76K
Operating cash flow 4.34%-10.82M-11.92%-11.32M-14.69%-10.11M-97.83%-8.82M40.59%-4.46M10.67%-7.5M---8.4M
Investing cash flow
Cash flow from continuing investing activities -240.82%-197.06K-891.41%-57.82K89.20%-5.83K-160.61%-54K-39.74%-20.72K-38.63%-14.83K-10.7K
Net PPE purchase and sale -240.82%-197.06K-891.41%-57.82K89.20%-5.83K-160.61%-54K-39.74%-20.72K-38.63%-14.83K---10.7K
Cash from discontinued investing activities
Investing cash flow -240.82%-197.06K-891.41%-57.82K89.20%-5.83K-160.61%-54K-39.74%-20.72K-38.63%-14.83K---10.7K
Financing cash flow
Cash flow from continuing financing activities -35.40%6.13M3.62%9.49M8,129.98%9.16M-99.37%111.25K17.79M15.61M
Net issuance payments of debt -------------200.00%-26.56K--26.56K--------
Net common stock issuance -36.02%6.19M3.85%9.67M3,483.17%9.32M-98.55%260K--17.88M------15.61M
Net other financing activities 67.74%-60.4K-16.84%-187.21K-31.14%-160.23K-0.90%-122.18K---121.1K--------
Cash from discontinued financing activities
Financing cash flow -35.40%6.13M3.62%9.49M8,129.98%9.16M-99.37%111.25K--17.79M------15.61M
Net cash flow
Beginning cash position -16.72%9.39M-7.84%11.28M-41.71%12.24M173.08%21M-49.43%7.69M90.05%15.21M--8M
Current changes in cash -159.41%-4.89M-96.46%-1.89M89.04%-960K-165.81%-8.76M277.07%13.31M-204.32%-7.52M--7.2M
End cash Position -52.08%4.5M-16.72%9.39M-7.84%11.28M-41.71%12.24M173.08%21M-49.43%7.69M--15.21M
Free cash from 3.10%-11.02M-12.43%-11.37M-14.06%-10.12M-98.12%-8.87M40.44%-4.48M10.61%-7.52M---8.41M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data